Storage of platelets in additive solution for up to 12 days with maintenance of good in-vitro quality

Transfusion

Volumn 44, Issue 8, 2004, Pages 1204-1211

  Van Der Meer, Pieter F ^a,b   Pietersz, Ruby N I ^a   Reesink, Henk W ^a  

^a Sanquin Bloedbank Regio Noordwest Amsterdam   (Netherlands)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRYL TRIHEXYL CITRATE; CITRIC ACID; POLYVINYLCHLORIDE; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD LEVEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; PLASMA; SCREENING TEST; THROMBOCYTE PRESERVATION;

ACETATES; BLOOD PLATELETS; BLOOD PRESERVATION; CITRATES; HUMANS; HYDROGEN-ION CONCENTRATION; PRESERVATIVES, PHARMACEUTICAL; SODIUM CHLORIDE; TIME FACTORS;

EID: 3343009736     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.04010.x     Document Type: Article

References (30)

1. Heddle NM, Klama L, Meyer R, et al. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion 1999;39:231-8.
2. De Wildt-Eggen J, Nauta S, Schrijver JG, et al. Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study. Transfusion 2000;40:398-403.
3. Knutson F, Alfonso R, Dupuis K, et al. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang 2000;78:209-16.
4. Adams GA, Rock G. Storage of human platelet concentrates in an artificial medium without dextrose. Transfusion 1988;28:217-20.
5. Bertolini F, Rebulla P, Riccardi D, et al. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium. Transfusion 1989;29:605-9.
6. Fijnheer R, Veldman HA, van den Eertwegh AJ, et al. In vitro evaluation of buffy-coat-derived platelet concentrates stored in a synthetic medium. Vox Sang 1991;60:16-22.
7. Van Rhenen DJ, Vermeij H, Kappers-Klunne M, Payrat JM. Evaluation of a new citrate-acetate-NaCl platelet additive solution for the storage of white cell-reduced platelet concentrates obtained from half-strength CPD pooled buffy coats. Transfusion 1995;35:50-3.
8. Gulliksson H, Eriksson L, Hogman CF, Payrat JM. Buffy-coat-derived platelet concentrates prepared from half-strength citrate CPD and CPD whole-blood units. Comparison between three additive solutions: in vitro studies. Vox Sang 1995;68:152-9.
9. De Wildt-Eggen J, Schrijver JG, Smid WM, et al. Platelets stored in a new-generation container differences between plasma and platelet additive solution II. Vox Sang 1998;75:218-23.
10. Van der Meer PF, Pietersz RN, Tiekstra MJ, et al. WBC-reduced platelet concentrates from pooled buffy coats in additive solution an evaluation of in vitro and in vivo measures. Transfusion 2001;41:917-22.
11. Gulliksson H, AuBuchon JP, Vesterinen M, et al. Storage of platelets in additive solutions: a pilot in vitro study of the effects of potassium and magnesium. Vox Sang 2002;82:131-6.
12. Van der Meer PF, Pietersz RN, Reesink HW. Comparison of two platelet additive solutions. Transfus Med 2001;11:193-7.
13. Yuasa T, Ohto H, Suzuki A, Shishido F. New plasma-reduced synthetic media, Fukushima cocktails, for the storage of platelets for transfusion. Transfus Sci 2000;23:37-46.
14. De Wildt-Eggen J, Schrijver JG, Bins M, Gulliksson H. Storage of platelets in additive solutions: effects of magnesium and/or potassium. Transfusion 2002;42:76-80.
15. Gulliksson H, AuBuchon JP, Cardigan R, et al. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium. The Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Vox Sang 2003;85:199-205.
16. Pietersz RNI, Engelfriet CP, Reesink HW, et al. Detection of bacterial contamination of platelet concentrates: international forum. Vox Sang 2003;85:224-39.
17. Van der Meer PF, Pietersz RN, Reesink HW. Leukoreduction of platelet concentrates using a "polishing" filter. Vox Sang 2000;79:27-33.
18. Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998;38:31-40.
19. Kunicki TJ, Tuccelli M, Becker GA, Aster RH. A study of variables affecting the quality of platelets stored at "room temperature." Transfusion 1975;15:414-21.
20. Fratantoni JC, Poindexter BJ, Bonner RF. Quantitative assessment of platelet morphology by light scattering: a potential method for the evaluation of platelets for transfusion. J Lab Clin Med 1984;103:620-31.
21. Ishikawa Y, Sasakawa S. Membrane potential of stored platelets and its effect on platelet functions. Thromb Res 1987;45:265-73.
22. Bara M, Guiet-Bara A, Durlach J. Regulation of sodium and potassium pathways by magnesium in cell membranes. Magnes Res 1993;6:167-77.
23. Gawaz M, Ott I, Reininger AJ, Neumann FJ. Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Thromb Haemost 1994;72:912-8.
24. Weis-Fogh US. The effect of citrate, calcium, and magnesium ions on the potassium movement across the human platelet membrane. Transfusion 1985;25:339-42.
25. Sheu JR, Hsiao G, Shen MY, et al. Mechanisms involved in the antiplatelet activity of magnesium in human platelets. Br J Haematol 2002;119:1033-41.
26. Bertolini F, Rebulla P, Porretti L, Murphy S. Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium. Transfusion 1992;32:9-16.
27. Holme S, Heaton WA, Whitley P. Platelet storage lesions in second-generation containers: correlation with in vivo behaviour with storage up to 14 days. Vox Sang 1990;59:12-8.
28. Slichter SJ, Pellham E, Kay Jones M, et al. Extension of platelet storage to 7 days in PlasmaLyte versus plasma: in vivo and in vitro evaluations. Blood 2001;98:448a-9a.
29. Van Rhenen D, Gulliksson H, Cazenave JP, et al. euroSPRITE trial. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003;101:2426-33.
30. Gulliksson H, Larsson S, Kumlien G, Shanwell A. Storage of platelets in additive solutions: effects of phosphate. Vox Sang 2000;78:176-84.